tonefotografia / shutterstock.com
BioMarin Pharmaceutical, a drugs company focusing on genetic diseases, has filed a complaint against Dr Reddy’s Laboratories for alleged patent infringement over the drug Kuvan (sapropterin dihydrochloride).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Dr. Reddy’s Laboratories, BioMarin Pharmaceutical, ANDA, FDA, Kuvan, patent, genetics